-
Crippa, Demise claim Paris marathon victories
-
Union Berlin appoint first female coach after Baumgart sacking
-
Legendary Indian singer Asha Bhosle dies aged 92
-
Finance minister favourite as Benin votes for president
-
Imagine Dragons frontman chases childhood video game dream
-
Teenage sprint star Gout powers to 200m win in blistering 19.67sec
-
China's energy strategy pays off as Mideast war cramps supplies: analysts
-
Hungarians vote in closely watched election, with Orban's rule on line
-
Mideast war takes a bite out of Filipino street food vendors
-
Crime-weary Peru votes for ninth president in a decade
-
Vance says talks failed to reach deal with Iran on ending Mideast war
-
New York's teen spirit frustrates Messi, Miami
-
Vance says talks failed to reach agreement with Iran
-
'Stop hiring humans'? Silicon Valley confronts AI job panic
-
Force rue missed opportunities after another Super Rugby defeat
-
Ireland's Lowry becomes first with two Masters aces
-
'Mental toughness' hailed after Reds snap 15-year Crusaders curse
-
Justin Bieber fans flood Coachella festival for headlining show
-
Saturday charge has Young in sight of first major title at Masters
-
McIlroy looking for answers after squandered Masters lead
-
McIlroy and Young share lead after Masters third round
-
Lavelle marks 100th cap with goal in US win over Japan
-
Artemis crew urges unity on 'lifeboat' Earth
-
US, Iran talks extend into second day as strait showdown deepens
-
Former heavyweight king Fury outpoints Makhmudov, calls out Joshua
-
Former heavyweight king Fury outpoints Makhmudov on ring return
-
Two-time champ Scheffler surges up Masters leaderboard
-
McIlroy scrambles to hold off rivals and keep Masters lead
-
Milan's Serie A title hopes in tatters after shock Udinese defeat, Juve fourth
-
Easter truce between Russia and Ukraine falters
-
US warships transit Strait of Hormuz in mine clearance op
-
Playoff seedings on line as grueling NBA regular-season comes to close
-
Ngumoha's 'special' impact no surprise to Slot
-
Arsenal suffer major title blow as Liverpool earn vital win
-
US, Iran hold high-level peace talks in Pakistan
-
Over 200 arrested at pro-Palestinian rally in London
-
McIlroy tees off with six-stroke Masters lead
-
Record-breaking Bayern march closer to Bundesliga title
-
World champions England make winning start to Women's Six Nations
-
Yamal shines as Barca thrash Espanyol to extend Liga lead
-
Drean double sets Toulon up for Champions Cup semi against Leinster
-
Salah, Ngumoha ease Liverpool crisis with Fulham win
-
Arsenal suffer huge title blow as Liverpool earn vital win
-
Samson smashes hundred as Chennai notch first win of IPL season
-
Bayern Munich set Bundesliga record with 102nd goal of season
-
Milan's Serie A title hopes in tatters after shock Udinese defeat
-
Alcaraz and Sinner battle for No.1 spot in Monte Carlo final
-
In fiery speech, Pope Leo says 'Enough to war!'
-
Andreeva to face Potapova in Linz WTA final
-
Holders Italy, Britain into BJK Cup finals, USA knocked out
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.
ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.
"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."
Solving the $1 million per study problem
While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.
This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.
Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.
The results are compelling:
Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.
$141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.
51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.
Shaping the Future of Study Operations
Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.
Site Identification & Feasibility
Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.
Study Startup
AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.
Remote Monitoring
AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.
Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.
Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.
All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025
Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/
About Florence Healthcare
Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.
Contact Information
Seema Sheth-Voss
[email protected]
(888) 829-0896
SOURCE: Florence Healthcare
View the original press release on ACCESS Newswire
A.Moore--AT